← Back to Search

Non-Adjusted Intervention Video for Social Stigma

N/A

Waitlist Available

Led By Yuval Neria, PhD

Research Sponsored by Research Foundation for Mental Hygiene, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after the intervention

Awards & highlights

Study Summary

This trial will research the mental health impacts of COVID-19 on healthcare workers & other essential workers, esp. young adults & women, to develop & test cost-effective interventions.

Eligible Conditions

Social Stigma
Help-Seeking Behavior

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Help Seeking Intentions (3 items of the ATSPPH)

Help Seeking Intentions (3 items of the Attitudes Toward Seeking Professional Psychological Help) (ATSPPH)

Stigma (3 items of the SSOSH-3)

+1 more

Secondary outcome measures

Number of Referral Clicks

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Non-Adjusted Intervention VideoExperimental Treatment1 Intervention

Participants will watch a 2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, without any language alluding to her particular identity characteristics.

Group II: Adjusted Content Intervention VideoExperimental Treatment1 Intervention

Participants will watch a 2-3-minute video in which an empowered essential worker protagonist shares her COVID-19 related mental health problems and describes how she was able to confront her mental health problems and pursuit of mental health care, using language that speaks to the specific experience of being a young Latina woman.

Group III: Control ArmActive Control1 Intervention

Participants will watch a control video discussing daily activities.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Research Foundation for Mental Hygiene, Inc.Lead Sponsor

66 Previous Clinical Trials

19,518 Total Patients Enrolled

Columbia UniversityOTHER

1,431 Previous Clinical Trials

2,459,431 Total Patients Enrolled

Yuval Neria, PhDPrincipal InvestigatorNYSPI and Columbia University

8 Previous Clinical Trials

6,390 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity for me to participate in this medical experiment?

"Admission to this clinical trial is conditional on the individual's age (between 18 and 35) and social stigma. 1400 participants are needed in total for this research initiative."

Answered by AI

Is the age limit for recruitment into this investigation higher than 65 years?

"This clinical trial seeks applicants aged between 18 and 35. There are 6 studies available for those under the legal age of consent, while 23 trials are open to people above 65 years old."

Answered by AI

Is this experiment in search of new participants right now?

"The trial, which was first published on May 1st 2023 and last modified on April 20th has concluded its search for participants. As of now, clinicaltrials.gov records that 30 other medical studies are actively recruiting patients across the world."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2

Yuval Y Neria 2023. "Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05826132.